Clinical Trials Browser

Phase 2 × INDUSTRY × resiniferatoxin × Clear all

NCT05067257 2024-03-18

Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer

Phase 2 Suspended

Cancer Pain, Pain, Pain, Intractable